赛通姆治疗 CTMX
$2.19 +$0.05 (+2.34%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $2.19 0.00%
开盘$2.24
昨收$2.14
当日区间$2.12 – $2.27
成交量2.73M
市值$477.43M
市盈率（TTM）–
股息率–
CTMX 相关新闻
匹配 CytomX 或代码 CTMX 的头条新闻，按最新排序。
- Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12
- Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $16
- J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11
- J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11 负面
- Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11
- A Quick Look at Today's Ratings for CytomX(CTMX.US), With a Forecast Between $11 to $16
- Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $15
- Wolfe Research Initiates CytomX(CTMX.US) With Buy Rating, Announces Target Price $6
- Oppenheimer Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12
- H.C. Wainwright Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11 负面
- Cantor Fitzgerald Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $10 正面
- Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10
- Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $12 正面
- Barclays Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $16 正面
- Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $15 正面
暂无评论——快来第一个聊聊 CTMX。